ATP7B and Wilson disease: In conclusion, we have presented here the results and the application of different methods for the detection of alterations in the exon copy number within the ATP7B. Our data highlights that MLPA is a powerful tool to screen for intragenic deletions in WD patients in whom previous analyses of the ATP7B failed to identify one or both mutations.